110 related articles for article (PubMed ID: 24199803)
21. Keratomycosis caused by Aspergillus viridinutans: an Aspergillus fumigatus-resembling mold presenting distinct clinical and antifungal susceptibility patterns.
Shigeyasu C; Yamada M; Nakamura N; Mizuno Y; Sato T; Yaguchi T
Med Mycol; 2012 Jul; 50(5):525-8. PubMed ID: 22329455
[TBL] [Abstract][Full Text] [Related]
22. Disseminated invasive aspergillosis in an apparently immunocompetent host.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
[TBL] [Abstract][Full Text] [Related]
23. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
24. Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.
Alvarez CA; Wiederhold NP; McConville JT; Peters JI; Najvar LK; Graybill JR; Coalson JJ; Talbert RL; Burgess DS; Bocanegra R; Johnston KP; Williams RO
J Infect; 2007 Jul; 55(1):68-74. PubMed ID: 17360039
[TBL] [Abstract][Full Text] [Related]
25. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
Petraitiene R; Petraitis V; Groll AH; Sein T; Piscitelli S; Candelario M; Field-Ridley A; Avila N; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2001 Mar; 45(3):857-69. PubMed ID: 11181372
[TBL] [Abstract][Full Text] [Related]
26. Pattern recognition receptors and their role in invasive aspergillosis.
Gresnigt MS; Netea MG; van de Veerdonk FL
Ann N Y Acad Sci; 2012 Dec; 1273():60-7. PubMed ID: 23230838
[TBL] [Abstract][Full Text] [Related]
27. Immune response to Aspergillus fumigatus in compromised hosts: from bedside to bench.
Chai LY; Vonk AG; Kullberg BJ; Netea MG
Future Microbiol; 2011 Jan; 6(1):73-83. PubMed ID: 21162637
[TBL] [Abstract][Full Text] [Related]
28. Intracranial aspergillosis in children successfully treated with antifungal therapy and surgical intervention.
Giacchino M; Chiapello N; Riva C; Scolfaro C; Pultrone M; Valera M; Peretta P; Piglione M; Di Rosa G; Tovo PA
Pediatr Infect Dis J; 2006 Apr; 25(4):379-81. PubMed ID: 16567999
[TBL] [Abstract][Full Text] [Related]
29. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus.
Chamilos G; Kontoyiannis DP
Drug Resist Updat; 2005 Dec; 8(6):344-58. PubMed ID: 16488654
[TBL] [Abstract][Full Text] [Related]
30. Infectious diseases. Farm fungicides linked to resistance in a human pathogen.
Enserink M
Science; 2009 Nov; 326(5957):1173. PubMed ID: 19965440
[No Abstract] [Full Text] [Related]
31. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human macrophage colony-stimulating factor augments pulmonary host defences against Aspergillus fumigatus.
Gonzalez CE; Lyman CA; Lee S; Del Guercio C; Roilides E; Bacher J; Gehrt A; Feuerstein E; Tsokos M; Walsh TJ
Cytokine; 2001 Jul; 15(2):87-95. PubMed ID: 11500084
[TBL] [Abstract][Full Text] [Related]
33. Surface display of Gaussia princeps luciferase allows sensitive fungal pathogen detection during cutaneous aspergillosis.
Donat S; Hasenberg M; Schäfer T; Ohlsen K; Gunzer M; Einsele H; Löffler J; Beilhack A; Krappmann S
Virulence; 2012; 3(1):51-61. PubMed ID: 22286700
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.
Seyedmousavi S; Brüggemann RJ; Melchers WJ; Rijs AJ; Verweij PE; Mouton JW
J Antimicrob Chemother; 2013 Feb; 68(2):385-93. PubMed ID: 23129729
[TBL] [Abstract][Full Text] [Related]
35. Aspergillus species intrinsically resistant to antifungal agents.
Van Der Linden JW; Warris A; Verweij PE
Med Mycol; 2011 Apr; 49 Suppl 1():S82-9. PubMed ID: 20662634
[TBL] [Abstract][Full Text] [Related]
36. Menacing mold: the molecular biology of Aspergillus fumigatus.
Brakhage AA; Langfelder K
Annu Rev Microbiol; 2002; 56():433-55. PubMed ID: 12142473
[TBL] [Abstract][Full Text] [Related]
37. In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
Manavathu EK; Cutright JL; Chandrasekar PH
Antimicrob Agents Chemother; 2005 Jan; 49(1):428-30. PubMed ID: 15616327
[TBL] [Abstract][Full Text] [Related]
38. Multidrug resistance in Aspergillus fumigatus.
Warris A; Weemaes CM; Verweij PE
N Engl J Med; 2002 Dec; 347(26):2173-4. PubMed ID: 12501236
[No Abstract] [Full Text] [Related]
39. Invasive subglottal aspergillosis in a patient with severe aplastic anemia: a case report.
Nagasawa M; Itoh S; Tomizawa D; Kajiwara M; Sugimoto T; Kumagai J
J Infect; 2002 Apr; 44(3):198-201. PubMed ID: 12099752
[TBL] [Abstract][Full Text] [Related]
40. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
Walsh TJ; Petraitis V; Petraitiene R; Field-Ridley A; Sutton D; Ghannoum M; Sein T; Schaufele R; Peter J; Bacher J; Casler H; Armstrong D; Espinel-Ingroff A; Rinaldi MG; Lyman CA
J Infect Dis; 2003 Jul; 188(2):305-19. PubMed ID: 12854088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
